Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Efficacy, Safety, and Immunogenicity of RotaTeq Among Infants in Asia and Africa.

Trial Profile

Efficacy, Safety, and Immunogenicity of RotaTeq Among Infants in Asia and Africa.

Completed
Phase of Trial: Phase III

Latest Information Update: 18 Apr 2017

At a glance

  • Drugs Rotavirus W179-9 vaccine (Primary)
  • Indications Gastroenteritis; Rotavirus infections
  • Focus Pharmacodynamics; Registrational; Therapeutic Use
  • Sponsors Merck & Co
  • Most Recent Events

    • 17 Oct 2016 Results of a post-hoc analysis were published in the Pediatric Infectious Disease Journal
    • 06 Aug 2010 Results in children from Africa published in Lancet.
    • 06 Aug 2010 Results in children from Asia published in Lancet.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top